- 专利标题: Agents for reversing epigenetic silencing of genes
-
申请号: US14708045申请日: 2015-05-08
-
公开(公告)号: US10227654B2公开(公告)日: 2019-03-12
- 发明人: William G. Nelson , Srinivasan Yegnasubramanian , Xiaohui Lin , Traci J. Speed , Zachery Reichert
- 申请人: The Johns Hopkins University
- 申请人地址: US MD Baltimore
- 专利权人: The Johns Hopkins University
- 当前专利权人: The Johns Hopkins University
- 当前专利权人地址: US MD Baltimore
- 代理机构: DLA Piper LLP (US)
- 主分类号: A61K31/444
- IPC分类号: A61K31/444 ; A61K31/404 ; A61K31/4188 ; A61K31/381 ; A61K31/4439 ; C12Q1/6886 ; A61K31/4245 ; A61K31/433 ; A61K31/136 ; A61K31/517 ; A61K31/519 ; G01N33/68 ; G01N33/50 ; A61K31/4184
摘要:
The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.
公开/授权文献
- US20150252438A1 AGENTS FOR REVERSING EPIGENETIC SILENCING OF GENES 公开/授权日:2015-09-10
信息查询
IPC分类: